LF/HF ratio · vagal tone · HRV

The LF/HF Ratio Is Not Vagal Tone: Autonomic Testing in Gut Patients

The LF/HF ratio is not a measure of vagal tone: it climbs as autonomic input to the heart is removed. RMSSD and high-frequency power are the heart rate variability indices that carry vagal information, measured serially against the patient’s own baseline under matched conditions.

Heart rate variability is a cardiac proxy with a consistent signal in functional and inflammatory gut disease. Its value depends on reporting the right index, under matched conditions, against the same patient.

The LF/HF ratio is still printed on consumer devices and in some reports as sympathovagal balance. In a physiology review of that ratio, it rose from 1.1 to 8.4 when most autonomic input to the heart was removed. An index that climbs as the nerve is taken away cannot be read as vagal tone, and it should not anchor a clinical decision in a patient with functional gut symptoms.

Chapter 3 of The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, shown on camera as Two Doctors, One Nerve, argues that bowel symptoms and anxiety in the same patient are one autonomic and inflammatory problem split across two specialties. Measura [Cardiometabolic and Autonomic Health Analysis] measures the cardiac side of that problem and reports to the ordering physician. The questions for a practice are which indices carry vagal information, how large the gut signal really is, and what a finding should change.

Does the LF/HF ratio measure vagal tone?

The Task Force standards set high frequency at 0.15 to 0.40 Hz and made five minutes the short-term recording standard. Two constraints follow. High-frequency power indexes vagal tone only while respiration stays inside that band, roughly nine to twenty-four breaths per minute, which is why RMSSD, less affected by breathing, is the preferred vagal index for most purposes. Recording lengths are also not interchangeable; 24-hour, five-minute and ultra-short values are distinct measurements.

The ratio’s problems are anatomical. Parasympathetic blockade removes at least half of low-frequency power, the sympathetic share of that band is at best a quarter, sympathetic activation may shift high-frequency power by up to ten percent, and prevailing heart rate biases the ratio with no change in nerve activity. Denervated transplanted hearts still show two to eight percent of normal respiratory variation. Report RMSSD and high-frequency power, and leave LF/HF uninterpreted.

Between-subject comparison is the weak use of these indices. Respiratory sinus arrhythmia often correlates strongly with vagal control inside one person and only modestly across people, so the defensible clinical use is serial measurement against the patient’s own baseline under matched conditions. A Measura heart rate variability recording can be repeated for that purpose, and cardiac autonomic reflex tests add standardized provocations to the resting picture.

Is heart rate variability lower in gut disorders?

Pooled across inflammatory bowel disease, RMSSD sat at a standardized difference of -0.71 against controls; removing one influential study shrank the ulcerative colitis estimate to -0.41. In irritable bowel syndrome, a high-frequency deficit appeared in short recordings (-0.35) and was essentially absent in long ones (-0.06). Only 2 of 28 studies in that review confirmed a blinded reader, and its authors judged heart rate variability not yet suitable for monitoring symptoms in either condition.

Within single cohorts the signal is clearer. Among 253 participants with 24-hour recordings, the vagal index ran 39.99 ms in controls and 16.87 ms in functional dyspepsia, and the normal postprandial organization of gastric slow waves was blunted alongside it. In adjusted models, sleep quality outperformed anxiety and depression scores as a predictor of vagal tone, with a coefficient of -1.726 and an adjusted R-squared of 0.583. In Crohn’s disease, vagal tone correlated inversely with circulating TNF (r = -0.48); in irritable bowel syndrome, with plasma epinephrine (r = -0.39); in no group did it follow affect scores.

Stated at its tier, this is a soft instrument with a consistent direction, sensitive to study design, and a proxy for cardiac rather than abdominal vagal tone. It does not measure vagal traffic from the gut. The practice’s position is that it is worth measuring anyway, because the direction holds across cohorts and pooled reviews, and because trial exclusions remove the patients who carry the most risk.

Which gut patients should have autonomic testing?

Reasonable candidates include adults with functional dyspepsia or irritable bowel syndrome whose anxiety is managed on a separate track, patients with inflammatory bowel disease and persistent symptoms, and the cardiometabolic patient the pooled gut analysis excluded: cardiovascular disease, diabetes, kidney failure, alcoholism, or treatment with a beta-blocker or calcium channel blocker. Those groups can be written into selection criteria, with the medication list recorded as a confounder.

A low, reproducible vagal index changes management in three ways. It supports handling the bowel and the anxiety as one case, with gastroenterology and behavioral plans coordinated instead of run in parallel. It moves sleep assessment up the list, since sleep was the strongest predictor in the dyspepsia cohort. And it prompts a look at the metaflammation terrain feeding the ascending signal, through laboratory panels and the broader autonomic nervous system testing battery. A normal value does not exclude a gut-driven problem, and a low one is not a diagnosis.

Can a change in heart rate variability prove an anti-inflammatory vagal effect?

Dr. Padda learned the vagus-to-spleen inflammatory reflex as settled physiology and taught it that way. The route has not held. In rats, vagotomy left endotoxin-induced plasma TNF unchanged while section of the greater splanchnic nerve raised it about fivefold, and anatomical tracing in mice found no significant vagal motor supply to the spleen. Across 15 stimulation studies, pooled effects on TNF, interleukin-6 and interleukin-1 beta were not significant, and a higher risk of bias predicted a larger reported effect.

Two reporting consequences follow. A change in heart rate variability after an intervention is not evidence of an anti-inflammatory vagal effect. And interventions named for vagal tone may leave it untouched: across 13 randomized trials and 965 participants with cardiovascular disease, heart rate variability biofeedback reduced diastolic pressure by 3.23 mmHg without shifting high-frequency power. Stimulation devices and biofeedback programs are treatments, not measurements, and are not part of the Measura protocol.

How should heart rate variability be recorded for serial testing?

Reproducibility is the entire value of a serial autonomic measure, so the protocol has to fix what the physiology responds to: the same device and analysis method, the same time of day and posture, spontaneous breathing with no breathing exercise beforehand, a documented recording length, and a current medication list flagging agents that alter heart rate. Paced breathing inflates almost every index, and two spectral methods applied to one recording return different values. Standing orders make those conditions the default, staffing and workflow covers who runs the recording, and results enter the record as dated, comparable values. For patients followed over time, between-visit monitoring keeps the trend in view. The anatomy behind the proxy is covered in the opening physician post in this series.

The complete evidence file, including the pooled results that shrink the effect, is in the Deep Dive companion. The preceding installment covers the medication load feeding the first brain’s signal to the second brain, in deprescribing starts with a baseline.

Frequently asked questions

What does a high LF/HF ratio mean?

Less than most apps imply. The ratio is printed as sympathovagal balance, yet in a physiology review it rose from 1.1 to 8.4 when most autonomic input to the heart was removed. Prevailing heart rate also shifts it with no change in nerve activity. A high ratio is not evidence of a stressed nervous system or of low vagal tone, and it should not anchor a clinical decision.

What do LF and HF mean in heart rate variability?

They are frequency bands of heart rate variability. High frequency, 0.15 to 0.40 Hz under the Task Force standards, follows breathing and indexes vagal tone while respiration stays between roughly nine and twenty-four breaths per minute. Low frequency is not a sympathetic measure: parasympathetic blockade removes at least half of its power, and the sympathetic share is at best a quarter.

Should I worry if my heart rate variability is low?

A single low value is a reason for a closer look, not a diagnosis. A low vagal index that reproduces under matched conditions supports treating bowel symptoms and anxiety as one case, moves sleep assessment up the list, and prompts a look at the metabolic and inflammatory terrain. A normal value does not exclude a gut-driven problem, so the trend against your own baseline matters most.

Should the LF/HF ratio appear in a clinical autonomic report?

Not as a measure of sympathovagal balance. The ratio rose from 1.1 to 8.4 when most autonomic input was removed, low-frequency power is at least half parasympathetic, and heart rate alone shifts the ratio. If a system prints it, label it a spectral ratio and base interpretation on RMSSD and high-frequency power. Interpreting the report.

Is RMSSD or high-frequency power preferable in gut patients?

RMSSD, for most uses. High-frequency power indexes vagal tone only when breathing falls between roughly nine and twenty-four breaths per minute, and slower breathers push vagal activity out of the band. RMSSD is less sensitive to respiration. Whichever is reported, keep the recording length and analysis method constant between visits. What makes a good vascular and autonomic tester.

Does a low vagal index confirm gut-driven inflammation?

No. It is a cardiac proxy associated with inflammatory markers and with gut disorders in group data, not a measurement of abdominal vagal traffic or of mucosal inflammation. Treat it as a terrain marker that justifies a closer look at inflammation, sleep and sympathetic load, alongside the gastrointestinal workup ordered elsewhere. Clinical rationale.

Which factors confound heart rate variability in these patients?

Breathing rate, posture, momentary physical activity, prevailing heart rate, recording length and the analysis method all shift the values, and beta-adrenergic tone alters respiratory sinus arrhythmia. Beta-blockers and calcium channel blockers were exclusion criteria in the pooled gut analysis, so document them and compare each patient only with their own prior recordings. Physician questions.

How should serial results be documented?

Record the index reported, recording length, time, posture, device, analysis method, breathing conditions and current medications with every value. That makes a trend defensible and lets a colleague reproduce the measurement. Document the management decision each result informed, including a decision that nothing changed. Getting diagnostic results into the chart.

References

• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation, 93(5), 1043-65. https://pubmed.ncbi.nlm.nih.gov/8598068/
• Laborde, S., Mosley, E., & Thayer, J. F. (2017). Heart rate variability and cardiac vagal tone in psychophysiological research – recommendations for experiment planning, data analysis, and data reporting. Frontiers in Psychology, 8, 213. https://doi.org/10.3389/fpsyg.2017.00213
• Billman, G. E. (2013). The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Frontiers in Physiology, 4, 26. https://doi.org/10.3389/fphys.2013.00026
• Grossman, P., & Taylor, E. W. (2007). Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biological Psychology, 74(2), 263-85. https://doi.org/10.1016/j.biopsycho.2005.11.014
• Kim, K.-N., Yao, Y., & Ju, S.-Y. (2020). Heart rate variability and inflammatory bowel disease in humans: a systematic review and meta-analysis. Medicine, 99(48), e23430. https://doi.org/10.1097/MD.0000000000023430
• Sadowski, A., Dunlap, C., Lacombe, A., & Hanes, D. (2021). Alterations in heart rate variability associated with irritable bowel syndrome or inflammatory bowel disease: a systematic review and meta-analysis. Clinical and Translational Gastroenterology, 12(1), e00275. https://doi.org/10.14309/ctg.0000000000000275
• Du, L., Yang, J., Jiang, L., Zeng, G., Shu, Y., & Bi, B. (2026). Postprandial attenuation of gastric slow waves in anxiety-depression, with and without functional dyspepsia: associations with heart rate variability and sleep quality. Frontiers in Medicine, 13, 1890716. https://doi.org/10.3389/fmed.2026.1890716
• Pellissier, S., Dantzer, C., Mondillon, L., Trocme, C., Gauchez, A.-S., Ducros, V., Mathieu, N., Toussaint, B., Fournier, A., Canini, F., & Bonaz, B. (2014). Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn’s disease and irritable bowel syndrome. PLoS One, 9(9), e105328. https://doi.org/10.1371/journal.pone.0105328
• de Melo, P. S., Gianlorenco, A. C., Marduy, A., Kim, C. K., Choi, H., Song, J.-J., & Fregni, F. (2024). A mechanistic analysis of the neural modulation of the inflammatory system through vagus nerve stimulation: A systematic review and meta-analysis. Neuromodulation: Journal of the International Neuromodulation Society, 28(1), 43-53. https://doi.org/10.1016/j.neurom.2024.03.002
• Kaneko, K., Aikawa, G., Sakuramoto, H., Ota, Y., Oyama, Y., Tomooka, M., Naya, K., Fukunaga, T., Sugishima, K., & Yamada, T. (2026). Effects of heart rate variability biofeedback on cardiac autonomic function in patients with cardiovascular disease: a systematic review and meta-analysis. Applied Psychophysiology and Biofeedback. Advance online publication. https://doi.org/10.1007/s10484-025-09765-3

Related reading

• Deprescribing Starts With a Baseline, Not a Drug List
• Metabolic Endotoxemia: What to Measure When Zonulin Cannot
• Heart Rate Variability

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.